STUDY POPULATION. This study was a nonrandomized controlled, parallel-group intervention trial with an active study population of 50 consecutively enrolled children aged 5 to 18 years. The study children underwent egg OIT after confirming immunoglobulin (Ig)E-mediated egg allergy by using a double-blind, placebo-controlled egg food challenge (DBPCFC). The control group included 32 children who ...

STUDY POPULATION. This study was a nonrandomized controlled, parallel-group intervention trial with an active study population of 50 consecutively enrolled children aged 5 to 18 years. The study children underwent egg OIT after confirming immunoglobulin (Ig)E-mediated egg allergy by using a double-blind, placebo-controlled egg food challenge (DBPCFC). The control group included 32 children who ...

The times of oviposition are affected little by the use of a night lighting program. Egg shell weight is not changed by the time of oviposition. Egg weight, shell percentage and it's color vary according to the time of oviposition. The egg characteristics have not been affected by the use of night lighting. Night lighting reduces the percentage of eggs downgraded, in particular reducing by 37 %...

Background Cow’s milk allergy affects about 2-3 % of general population; the prevalence of egg allergy is 1-2% among childhood. According to the literature the development of tolerance for cow’s milk and for egg is reached in early childhood, in the majority of case. In addiction it is reported that over six years of age there is a significant decrease in the resolution rate both for cow’s milk...

Egg specific IgE levels are frequently used in combination with skin-prick tests to guide clinical decisions and to monitor egg allergy evolution in children. We compared both Immulite and ImmunoCAP egg specific IgE assays in egg allergic children, and found a linear correlation between both assays with a mean Immulite:ImmunoCAP ratio of 3. This is relevant information for clinicans wishing to ...

Peptide Microarray Immunoassay (PMI for brevity) is a novel technology that enables researchers to map a large number of proteomic measurements at a peptide level, providing information regarding the relationship between antibody response and clinical sensitivity. PMI studies aim at recognizing antigen-specific antibodies from serum samples and at detecting epitope regions of the protein antige...